Clinical Trial Update: Use of Empagliflozin to Treat Prediabetes [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating empagliflozin for treating prediabetes; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Prediabetes

Drugs mentioned

• Jardiance (empagliflozin)

Snippet

Sponsor: Oregon State University | Conditions: PreDiabetes, Prediabetic State | Phase 4 | Status: ACTIVE_NOT_RECRUITING